Assenagon Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-168,084
Closed -$25.8M 1481
2021
Q1
$25.8M Buy
168,084
+111,213
+196% +$15.1M 0.1% 168
2020
Q4
$7.13M Buy
+56,871
New +$6.36M 0.03% 303
2020
Q3
Sell
-39,063
Closed -$3.8M 1437
2020
Q2
$3.8M Buy
39,063
+7,072
+22% +$658K 0.02% 401
2020
Q1
$2.66M Sell
31,991
-69,975
-69% -$6.82M 0.02% 302
2019
Q4
$11.3M Buy
+101,966
New +$10.5M 0.07% 172
2019
Q3
Sell
-175,514
Closed -$17.4M 1153
2019
Q2
$17.4M Buy
175,514
+39,851
+29% +$3.8M 0.13% 112
2019
Q1
$15M Buy
135,663
+6,400
+5% +$669K 0.14% 136
2018
Q4
$11.9M Buy
+129,263
New +$13.1M 0.13% 126

Other funds holding PRAH

Assenagon Asset Management's PRAH Position: Q2 2021 in Review

Assenagon Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 168,084 shares — an estimated $25.8M sold.

Assenagon Asset Management first reported a position in PRAH in Q4 2018 and held it in 8 quarters. The position peaked at $25.8M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Assenagon Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 168,084 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $25.8M.
  • Assenagon Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 8 quarters.
  • Assenagon Asset Management's PRA Health Sciences, Inc. position peaked at $25.8M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Assenagon Asset Management's 13F filing for Q2 2021, filed 15 Jul 2021.